Results 131 to 140 of about 27,928 (247)

Anémie aplasique [Aplastic anemia] [PDF]

open access: yes
Aplastic anemia is a rare disease with a large differential diagnosis, including neoplastic origin as well as congenital bone marrow failure syndromes. Investigations must be quick and precise.
Zermatten, M.G.   +6 more
core   +1 more source

Stem cells and secretome in aplastic anaemia: a bibliometric analysis of global research trends (2018–2023) and future directions for regenerative therapies

open access: yesMedicinski Glasnik
Aim This study analyzed the research trends related to stem cells and secretome in aplastic anemia between 2018 and 2023 using a bibliometric approach to understand developments and research distribution in this field.
Citra Primavita Mayangsari   +5 more
doaj   +1 more source

Long‐Term Clinical and Molecular Dynamics in Hypoplastic Myelodysplastic Neoplasia Treated With Immunosuppressive Therapy

open access: yesEuropean Journal of Haematology, Volume 117, Issue 1, Page 274-278, July 2026.
ABSTRACT Myelodysplastic neoplasia (MDS) comprises heterogeneous clonal hematologic disorders characterized by peripheral cytopenia, bone marrow dysplasia, and a risk of leukemic transformation. A hypoplastic variant (MDS‐h) shares features with aplastic anemia and responds to immunosuppressive therapy (IST).
Hannes Treiber   +8 more
wiley   +1 more source

This Is Not a Myeloproliferative Neoplasm…

open access: yes
Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Stephanie Juané Kennedy
wiley   +1 more source

Utilization of electrodermal activity in nursing research: A mapping review

open access: yesJapan Journal of Nursing Science, Volume 23, Issue 3, July 2026.
Abstract Aim Electrodermal activity (EDA) reflects sympathetic nervous system activity related to emotions and cognition. This mapping review aimed to systematically identify and map existing nursing research that utilized EDA and examine future research prospects.
Satomi Yoda   +2 more
wiley   +1 more source

Current management of severe acquired aplastic anemia [PDF]

open access: yes, 2011
Overall survival in severe aplastic anemia has markedlyimproved in the past four decades due to advances in stem celltransplantation, immunosuppressive therapies and supportive care.Horse anti-thymocyte globulin plus cyclosporine is the ...
Phillip Scheinberg
core  

The Underestimated Role of Environmental Factors in the Prevention of Invasive Fungal Disease: Experience From a European Childhood Cancer Centre

open access: yesMycoses, Volume 69, Issue 7, July 2026.
ABSTRACT Background Immunocompromised children with hematologic malignancies or undergoing allogeneic haematopoietic stem cell transplantation (HSCT) are at high risk for invasive fungal diseases (IFDs). Reported incidence varies considerably due to heterogeneous diagnostic criteria, antifungal strategies and environmental conditions.
Stefano Malvestiti   +6 more
wiley   +1 more source

DIAGNOSTIC AND INDICATION OF BLOOD TRANSFUSION IN APLASTIC ANEMIA [PDF]

open access: yes, 2013
Aplastic anemia is a disease caused by a failure of the bone marrow to produce blood cells components resulting anemia with pancytopenia. symptoms will arise according to the blood cells decreased. Aplastic anemia is a rare and severe disease.
M Rizqa Fauzi
core  

Effect of autoimmune diseases on aplastic anemia: a bidirectional two-sample Mendelian randomization study

open access: yesHematology
Objectives: Numerous observational research avenues have identified a possible correlation between aplastic anemia and autoimmune diseases, rooted in analogous dysfunctional immune responses.
Qiuni Chen   +3 more
doaj   +1 more source

Breakthrough reactions in pediatric chemotherapeutic desensitization: Outcomes and associated risk factors

open access: yesPediatric Allergy and Immunology, Volume 37, Issue 7, July 2026.
Breakthrough reactions in Pediatric chemotherapeutic desensitization: outcomes and associated risk factors. Abstract Background Rapid drug desensitization (RDD) enables the safe reintroduction of chemotherapeutic agents in patients with hypersensitivity reactions (HSRs).
Pathitta Doradee   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy